1. Home
  2. PVBC vs MDWD Comparison

PVBC vs MDWD Comparison

Compare PVBC & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVBC
  • MDWD
  • Stock Information
  • Founded
  • PVBC 1913
  • MDWD 2000
  • Country
  • PVBC United States
  • MDWD Israel
  • Employees
  • PVBC N/A
  • MDWD N/A
  • Industry
  • PVBC Major Banks
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • PVBC Finance
  • MDWD Health Care
  • Exchange
  • PVBC Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • PVBC 192.7M
  • MDWD 184.8M
  • IPO Year
  • PVBC 2015
  • MDWD 2014
  • Fundamental
  • Price
  • PVBC $10.87
  • MDWD $17.64
  • Analyst Decision
  • PVBC Hold
  • MDWD Strong Buy
  • Analyst Count
  • PVBC 1
  • MDWD 1
  • Target Price
  • PVBC $12.00
  • MDWD $25.00
  • AVG Volume (30 Days)
  • PVBC 30.3K
  • MDWD 68.1K
  • Earning Date
  • PVBC 01-31-2025
  • MDWD 11-26-2024
  • Dividend Yield
  • PVBC N/A
  • MDWD N/A
  • EPS Growth
  • PVBC N/A
  • MDWD N/A
  • EPS
  • PVBC 0.32
  • MDWD N/A
  • Revenue
  • PVBC $55,219,000.00
  • MDWD $19,720,000.00
  • Revenue This Year
  • PVBC N/A
  • MDWD $10.37
  • Revenue Next Year
  • PVBC $5.90
  • MDWD $26.36
  • P/E Ratio
  • PVBC $34.15
  • MDWD N/A
  • Revenue Growth
  • PVBC N/A
  • MDWD N/A
  • 52 Week Low
  • PVBC $7.36
  • MDWD $11.04
  • 52 Week High
  • PVBC $12.32
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • PVBC 43.85
  • MDWD 49.76
  • Support Level
  • PVBC $10.51
  • MDWD $15.80
  • Resistance Level
  • PVBC $11.33
  • MDWD $19.60
  • Average True Range (ATR)
  • PVBC 0.24
  • MDWD 0.98
  • MACD
  • PVBC -0.04
  • MDWD 0.06
  • Stochastic Oscillator
  • PVBC 30.51
  • MDWD 48.42

About PVBC Provident Bancorp Inc. (MD)

Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: